Clinical Trial Update: Safety and Efficacy of Systemic Chemotherapy Plus PD-1 Inhibitor in Combination With Bevacizumab in Gastric Cancer With Peritoneal Metastasis [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating the safety and efficacy of combining systemic chemotherapy with a PD-1 inhibitor and Bevacizumab in patients with gastric cancer with…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastric Cancer
• Peritoneal Metastasis

Drugs mentioned

• Bevacizumab (bevacizumab)
• PD-1 inhibitor (unspecified)

Snippet

Sponsor: Union Hospital, Tongji Medical College, Huazhong University of Science and Technology | Conditions: Gastric Cancer Peritoneal Metastases | Phase 2 | Status: UNKNOWN